← Leaderboards
Stergios Moschos
Univ Of North Carolina Chapel Hill
$1,002,138
Attributed
$2,004,275
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $404.1K · FY2019–23$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,004,275 · 1
By mechanism
R01$2,004,275 · 1
Top collaborators
- Zibo Li5 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Toni Darville$28,754,279
- Zibo Li$7,321,417
- Corbin D Jones$5,254,232
- Lisa A Carey$11,034,788
- Raquel Sitcheran$3,309,063
Others in their field
Other Emerging Leaders on “Analog”
- John Hobbs · Suny At Stony Brook$41,239,084
- Christopher Bee · Suny At Stony Brook$41,239,084
- John Damon Chodera · Sloan-Kettering Inst Can Research$15,023,002
- Jeffrey Reich · Sparian Biosciences, Inc.$14,845,721
- Thomas Dick · Rbhs-New Jersey Medical School$14,469,725
- Terry Roemer · Prokaryotics, Inc.$14,198,753
Research focus
AnalogAmino Acid TransporterApoptosisApplications GrantsAnimal ModelBiopsyCancer CellCancer Cell LineCd8b1 GeneCd8-Positive T-LymphocytesCell LineCellsCheckpoint TherapyClinical ApplicationClinical DevelopmentClinical ImagingClinical PathwaysClinical ResearchClinical TranslationClinical TrialsCollaborationsComplementComplexCutaneous Melanoma
Grant awards (5)
Development of IDO PET agents for immunotherapy$396,007
R01 · FY2023 · CA
Development of IDO PET agents for immunotherapy$396,007
R01 · FY2022 · CA
Development of IDO PET agents for immunotherapy$404,087
R01 · FY2021 · CA
Development of IDO PET agents for immunotherapy$404,087
R01 · FY2020 · CA
Development of IDO PET agents for immunotherapy$404,087
R01 · FY2019 · CA